Factors affecting breast cancer risk reduction practices among California physicians

Fisher, 1998, Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study, J. Natl. Cancer Inst., 90, 1371, 10.1093/jnci/90.18.1371 Chlebowski, 1999, American society of clinical oncology technology assessment on breast cancer risk reduction strategies: tamoxifen and raloxifene, J. Clin. Oncol., 17, 1939, 10.1200/JCO.1999.17.6.1939 Levine, 2001, Chemoprevention of breast cancer. A joint guideline from the Canadian task force on preventive health care and the Canadian breast cancer initiative's steering committee on clinical practice guidelines for the care and treatment of breast cancer, CMAJ, 164, 1681 Kinsinger, 2002, Chemoprevention of breast cancer: a summary of the evidence for the U.S. Preventive Services Task Force, Ann. Intern. Med., 137, 59, 10.7326/0003-4819-137-1-200207020-00017 Miki, 1994, A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1, Science, 266, 66, 10.1126/science.7545954 Slattery, 1993, A comprehensive evaluation of family history and breast cancer risk. The Utah Population Database, JAMA, 270, 1563, 10.1001/jama.270.13.1563 Hartmann, 1999, Efficacy of bilateral prophylactic mastectomy in women with a family history of breast cancer, N. Engl. J. Med., 340, 77, 10.1056/NEJM199901143400201 Mezzetti, 1998, Population attributable risk for breast cancer: diet, nutrition, and physical exercise, J. Natl. Cancer Inst., 90, 389, 10.1093/jnci/90.5.389 Gammon, 1998, Recreational and occupational physical activities and risk of breast cancer, J. Natl. Cancer Inst., 90, 100, 10.1093/jnci/90.2.100 Huang, 1997, Dual effects of weight and weight gain on breast cancer risk, JAMA, 278, 1407, 10.1001/jama.278.17.1407 Smith-Warner, 1998, Alcohol and breast cancer in women: a pooled analysis of cohort studies, JAMA, 279, 535, 10.1001/jama.279.7.535 Powles, 1998, Interim analysis of the incidence of breast cancer in the Royal Marsden Hospital tamoxifen randomised chemoprevention trial, Lancet, 352, 98, 10.1016/S0140-6736(98)05071-5 Veronesi, 1998, Prevention of breast cancer with tamoxifen: preliminary findings from the Italian randomised trial among hysterectomised women. Italian Tamoxifen Prevention Study, Lancet, 352, 93, 10.1016/S0140-6736(98)85011-3 Newton, 1998, The physician's role in women's decision making about hormone replacement therapy, Obstet. Gynecol., 92, 580, 10.1016/S0029-7844(98)00272-5 McNagny, 1997, Use of postmenopausal hormone replacement therapy by African American women. The importance of physician discussion, Arch. Intern. Med., 157, 1337, 10.1001/archinte.157.12.1337 Draper, 1990, Perimenopausal women's views on taking hormone replacement therapy to prevent osteoporosis, BMJ, 300, 786, 10.1136/bmj.300.6727.786 Kinney, 1998, The effect of physician recommendation on enrollment in the breast cancer chemoprevention trial, Prev. Med., 27, 713, 10.1006/pmed.1998.0349 Dunn, 2001, From adjuvant therapy to breast cancer prevention: BCPT and STAR, Breast J., 7, 144, 10.1046/j.1524-4741.2001.007003144.x Pappas, 2002, Chemoprevention of breast cancer: current and future prospects, Cancer Metastasis Rev., 21, 311, 10.1023/A:1021219212638 Friedman, 2003, Primary care physicians' attitudes and practices regarding cancer genetics: a comparison of 2001 with 1996 survey results, J. Cancer Educ., 18, 91, 10.1207/S15430154JCE1802_11 Escher, 2000, Primary care physicians' knowledge and attitudes towards genetic testing for breast-ovarian cancer predisposition, Ann. Oncol., 11, 1131, 10.1023/A:1008319114278 Fry, 1999, GPs' views on their role in cancer genetics services and current practice, Fam. Pract., 16, 468, 10.1093/fampra/16.5.468 Doksum, 2003, Does knowledge about the genetics of breast cancer differ between nongeneticist physicians who do or do not discuss or order BRCA testing?, Genet. Med., 5, 99, 10.1097/01.GIM.0000055198.63593.32 Kripalani, 1996, Screening for breast and prostate cancer: a survey of Texas primary care physicians, Tex. Med., 92, 59 Dominick, 2003, Provider characteristics and mammography recommendation among women in their 40s and 50s, J. Womens Health (Larchmt), 12, 61, 10.1089/154099903321154158 Moy, 1995, Physician race and care of minority and medically indigent patients, JAMA, 273, 1515, 10.1001/jama.273.19.1515 Bernhardt, 1992, The organization and delivery of clinical genetics services, Pediatr. Clin. North Am., 39, 1, 10.1016/S0031-3955(16)38259-1 Pagon, 2002, GeneTests-GeneClinics: genetic testing information for a growing audience, Hum. Mutat., 19, 501, 10.1002/humu.10069 Myers, 1999, Genetic services for common complex disorders: surveys of health maintenance organizations and academic genetic centers, Genet. Med., 1, 272, 10.1097/00125817-199909000-00006 Mouchawar, 2001, Colorado family physicians' knowledge of hereditary breast cancer and related practice, J. Cancer Educ., 16, 33 Johnson, 1995, Presenting uncertainty in health risk assessment: initial studies of its effects on risk perception and trust, Risk Anal., 15, 485, 10.1111/j.1539-6924.1995.tb00341.x Sandman, 1994, High risk or low: how location on a “risk ladder” affects perceived risk, Risk Anal., 14, 35, 10.1111/j.1539-6924.1994.tb00026.x Sheridan, 2002, Numeracy and the medical student's ability to interpret data, Effect Clin. Pract., 5, 35 Woo, 1985, Screening procedures in the asymptomatic adult. Comparison of physicians' recommendations, patients' desires, published guidelines, and actual practice, JAMA, 254, 1480, 10.1001/jama.254.11.1480 Schwartz, 1991, Internists' practices in health promotion and disease prevention. A survey, Ann. Intern. Med., 114, 46, 10.7326/0003-4819-114-1-46